Terumo (TSE:4543) Common Stock : 円38,716 Mil (As of Dec. 2023)

View and export this data going back to 1982. Start your Free Trial

What is Terumo Common Stock?

Terumo's quarterly common stock stayed the same from Jun. 2023 (円38,716 Mil) to Sep. 2023 (円38,716 Mil) and stayed the same from Sep. 2023 (円38,716 Mil) to Dec. 2023 (円38,716 Mil).

Terumo's annual common stock stayed the same from Mar. 2021 (円38,716 Mil) to Mar. 2022 (円38,716 Mil) and stayed the same from Mar. 2022 (円38,716 Mil) to Mar. 2023 (円38,716 Mil).

Terumo Common Stock Historical Data

The historical data trend for Terumo's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Terumo Common Stock Chart

Terumo Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Common Stock

Get a 7-Day Free Trial

38,716.00

Terumo Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Common Stock	Get a 7-Day Free Trial															38,716.00	38,716.00	38,716.00	38,716.00	38,716.00

Terumo Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Terumo (TSE:4543) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (TSE:4543) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

TRUMY:USA TRUMF:USA TUO:Germany

Address

2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072

Website

https://www.terumo.com

Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.

Terumo (TSE:4543) Headlines

No Headlines